Boris Reznik presented an AI-enabled therapeutic framework for restoring youthful biology at a recent biotech forum. The approach integrates machine learning with longevity research alongside figures like Aubrey de Grey. This remains an early-stage conceptual pitch. Practitioners should view these claims as speculative until Immorta Bio provides peer-reviewed clinical data or specific model architectures.